Latest Regulatory Progress News

Bubs Australia Limited reports a strong FY25 with 29% revenue growth to $102.5 million, positive EBITDA turnaround, and sustained cash flow improvements. The company also advances its US market ambitions with a key FDA submission underway.

Artrya has launched its AI-powered Salix Coronary Anatomy platform in the U.S. and submitted its Coronary Plaque module for FDA clearance, marking a key step in its commercial expansion. A new five-year contract with Tanner Health signals the start of U.S. revenues.

Imricor Medical Systems reported significant regulatory and commercial progress in Q2 CY25, including CE mark approvals and expanded clinical trials, while maintaining a strong cash position.

Invictus Energy is preparing to drill the high-impact Musuma-1 exploration well outside its Mukuyu discovery area, while securing National Project Status for its Cabora Bassa Project in Zimbabwe.

Key Petroleum has moved its eight Potential Commercial Area applications into formal government evaluation, aiming to secure long-term tenure in Queensland’s Cooper-Eromanga Basin. Meanwhile, the company raised A$129,000 through an entitlement offer and is exploring international growth opportunities.

Lunnon Metals reports a first-ever gold Mineral Resource at Lady Herial alongside strong financial outcomes from its Scoping Study, while advancing negotiations with Gold Fields Ltd for ore processing.

Santana Minerals reports a robust update to its Bendigo-Ophir Gold Project with a new Pre-Feasibility Study showing enhanced economics and streamlined mine design, alongside advancing regulatory approvals in New Zealand.

St Barbara Limited is progressing towards the renewal of its Simberi Mining Lease, a critical step to extend operations and boost gold production through 2038. Final approval is anticipated in August 2025 after regulatory review delays.

Lithium Plus Minerals reports key regulatory and environmental milestones for its Lei Lithium Development Project, progressing towards a near-term direct shipped ore operation backed by a strategic partnership with Canmax Technologies.

Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.